skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Authors:
; ; ; ; ; ; ; ; ; ;  [1]
  1. Utah SU
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
NIHOTHER
OSTI Identifier:
1671112
Resource Type:
Journal Article
Journal Name:
Cell Res.
Additional Journal Information:
Journal Volume: 30; Journal Issue: 06, 2020
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Ma, Chunlong, Sacco, Michael Dominic, Hurst, Brett, Townsend, Julia Alma, Hu, Yanmei, Szeto, Tommy, Zhang, Xiujun, Tarbet, Bart, Marty, Michael Thomas, Chen, Yu, Wang, Jun, USF), and Ariz). Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. United States: N. p., 2020. Web. doi:10.1038/s41422-020-0356-z.
Ma, Chunlong, Sacco, Michael Dominic, Hurst, Brett, Townsend, Julia Alma, Hu, Yanmei, Szeto, Tommy, Zhang, Xiujun, Tarbet, Bart, Marty, Michael Thomas, Chen, Yu, Wang, Jun, USF), & Ariz). Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. United States. doi:10.1038/s41422-020-0356-z.
Ma, Chunlong, Sacco, Michael Dominic, Hurst, Brett, Townsend, Julia Alma, Hu, Yanmei, Szeto, Tommy, Zhang, Xiujun, Tarbet, Bart, Marty, Michael Thomas, Chen, Yu, Wang, Jun, USF), and Ariz). Mon . "Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease". United States. doi:10.1038/s41422-020-0356-z.
@article{osti_1671112,
title = {Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease},
author = {Ma, Chunlong and Sacco, Michael Dominic and Hurst, Brett and Townsend, Julia Alma and Hu, Yanmei and Szeto, Tommy and Zhang, Xiujun and Tarbet, Bart and Marty, Michael Thomas and Chen, Yu and Wang, Jun and USF) and Ariz)},
abstractNote = {},
doi = {10.1038/s41422-020-0356-z},
journal = {Cell Res.},
number = 06, 2020,
volume = 30,
place = {United States},
year = {2020},
month = {10}
}

Works referenced in this record:

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
journal, February 2020


Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
journal, March 2020


Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
journal, February 2020


Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
journal, April 2020


Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
journal, April 2020


N‐Terminal Methionine Processing
journal, April 2017

  • Wingfield, Paul T.
  • Current Protocols in Protein Science, Vol. 88, Issue 1
  • DOI: 10.1002/cpps.29

Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
journal, May 2017

  • Pedersen, Niels C.; Kim, Yunjeong; Liu, Hongwei
  • Journal of Feline Medicine and Surgery, Vol. 20, Issue 4
  • DOI: 10.1177/1098612X17729626

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
journal, March 2016


Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
journal, August 2012

  • Kim, Y.; Lovell, S.; Tiew, K. -C.
  • Journal of Virology, Vol. 86, Issue 21
  • DOI: 10.1128/JVI.01348-12

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
journal, September 2005

  • Shie, Jiun-Jie; Fang, Jim-Min; Kuo, Tun-Hsun
  • Bioorganic & Medicinal Chemistry, Vol. 13, Issue 17
  • DOI: 10.1016/j.bmc.2005.05.065

Validating Enterovirus D68-2A pro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2A pro Inhibitor
journal, January 2019

  • Musharrafieh, Rami; Ma, Chunlong; Zhang, Jiantao
  • Journal of Virology, Vol. 93, Issue 7
  • DOI: 10.1128/JVI.02221-18

Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents
journal, August 2008

  • Kuo, Chih-Jung; Shie, Jiun-Jie; Fang, Jim-Min
  • Bioorganic & Medicinal Chemistry, Vol. 16, Issue 15
  • DOI: 10.1016/j.bmc.2008.06.015

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
journal, February 2020


The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
journal, October 2003

  • Yang, H.; Yang, M.; Ding, Y.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 23
  • DOI: 10.1073/pnas.1835675100

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
journal, October 2016

  • Muramatsu, Tomonari; Takemoto, Chie; Kim, Yong-Tae
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 46
  • DOI: 10.1073/pnas.1601327113

Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
journal, May 2010

  • Li, Chunmei; Qi, Yifei; Teng, Xin
  • Journal of Biological Chemistry, Vol. 285, Issue 36
  • DOI: 10.1074/jbc.M109.095851

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design
journal, December 2007

  • Xue, Xiaoyu; Yu, Hongwei; Yang, Haitao
  • Journal of Virology, Vol. 82, Issue 5
  • DOI: 10.1128/JVI.02114-07

α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
journal, February 2020


Profiling of Substrate Specificity of SARS-CoV 3CLpro
journal, October 2010


Conservation of substrate specificities among coronavirus main proteases
journal, March 2002


Compassionate Use of Remdesivir for Patients with Severe Covid-19
journal, June 2020

  • Grein, Jonathan; Ohmagari, Norio; Shin, Daniel
  • New England Journal of Medicine, Vol. 382, Issue 24
  • DOI: 10.1056/NEJMoa2007016

First Case of 2019 Novel Coronavirus in the United States
journal, March 2020

  • Holshue, Michelle L.; DeBolt, Chas; Lindquist, Scott
  • New England Journal of Medicine, Vol. 382, Issue 10
  • DOI: 10.1056/NEJMoa2001191

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
journal, May 2020

  • Cao, Bin; Wang, Yeming; Wen, Danning
  • New England Journal of Medicine, Vol. 382, Issue 19
  • DOI: 10.1056/NEJMoa2001282

Coronaviruses — drug discovery and therapeutic options
journal, February 2016

  • Zumla, Alimuddin; Chan, Jasper F. W.; Azhar, Esam I.
  • Nature Reviews Drug Discovery, Vol. 15, Issue 5
  • DOI: 10.1038/nrd.2015.37

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
journal, August 2005

  • Simmons, G.; Gosalia, D. N.; Rennekamp, A. J.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 33
  • DOI: 10.1073/pnas.0505577102

Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
journal, July 2012

  • Schneider, Martha; Ackermann, Kerstin; Stuart, Melissa
  • Journal of Virology, Vol. 86, Issue 18
  • DOI: 10.1128/JVI.01001-12

Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N 4 -Hydroxycytidine
journal, February 2004

  • Barnard, Dale L.; Hubbard, Valerie D.; Burton, Jared
  • Antiviral Chemistry and Chemotherapy, Vol. 15, Issue 1
  • DOI: 10.1177/095632020401500102

Calpain research for drug discovery: challenges and potential
journal, November 2016

  • Ono, Yasuko; Saido, Takaomi C.; Sorimachi, Hiroyuki
  • Nature Reviews Drug Discovery, Vol. 15, Issue 12
  • DOI: 10.1038/nrd.2016.212

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
journal, April 2020


Biochemical Characterization of Recombinant Enterovirus 71 3C Protease with Fluorogenic Model Peptide Substrates and Development of a Biochemical Assay
journal, November 2014

  • Shang, Luqing; Zhang, Shumei; Yang, Xi
  • Antimicrobial Agents and Chemotherapy, Vol. 59, Issue 4
  • DOI: 10.1128/AAC.04698-14

Conformational Plasticity of the 2A Proteinase from Enterovirus 71
journal, April 2013


Bayesian Deconvolution of Mass and Ion Mobility Spectra: From Binary Interactions to Polydisperse Ensembles
journal, April 2015


Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers
journal, July 2016

  • Ma, Chunlong; Zhang, Jiantao; Wang, Jun
  • Molecular Pharmacology, Vol. 90, Issue 3
  • DOI: 10.1124/mol.116.105346

HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes
journal, July 2006

  • Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek
  • Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8
  • DOI: 10.1107/S0907444906019949

Molecular replacement with MOLREP
journal, December 2009

  • Vagin, Alexei; Teplyakov, Alexei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 1
  • DOI: 10.1107/S0907444909042589

REFMAC 5 for the refinement of macromolecular crystal structures
journal, March 2011

  • Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911001314

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Proteasome Inhibitor (MG-132) Treatment of mdx Mice Rescues the Expression and Membrane Localization of Dystrophin and Dystrophin-Associated Proteins
journal, October 2003

  • Bonuccelli, Gloria; Sotgia, Federica; Schubert, William
  • The American Journal of Pathology, Vol. 163, Issue 4
  • DOI: 10.1016/S0002-9440(10)63523-7

In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium
journal, July 2008

  • Mani, Santhosh K.; Shiraishi, Hirokazu; Balasubramanian, Sundaravadivel
  • American Journal of Physiology-Heart and Circulatory Physiology, Vol. 295, Issue 1
  • DOI: 10.1152/ajpheart.00085.2008

The protective effects and potential mechanism of Calpain inhibitor Calpeptin against focal cerebral ischemia–reperfusion injury in rats
journal, May 2010


Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury
journal, October 2008

  • Akdemir, Osman; Uçankale, Murat; Karaoğlan, Alper
  • Journal of Clinical Neuroscience, Vol. 15, Issue 10
  • DOI: 10.1016/j.jocn.2007.08.011

ALLN hinders HCT116 tumor growth through Bax-dependent apoptosis
journal, July 2013

  • Li, Shang-ze; Zhang, Hui-hui; Zhang, Jia-nong
  • Biochemical and Biophysical Research Communications, Vol. 437, Issue 2
  • DOI: 10.1016/j.bbrc.2013.06.088

Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study
journal, February 2013